Modulation of Melanocyte in Melasma Patients After Picosecond Laser Treatment

Overview

Journal J Cosmet Dermatol

Specialty Dermatology

Date 2024 Sep 16

PMID 39282999

Authors

Ching-Li Chen

Chih-Chiang Chen

Feng-Ling Tsai

I-Ling Chen

Ling Huang

Yu-Chun Yen

Chian-Yaw Hwang

Affiliations

Soon will be listed here.

Abstract

Background: Melasma is a therapeutically challenging hyperpigmented skin condition. Currently, there is a lack of in vivo observation regarding changes in melanin and dendritic melanocytes after laser treatment.

Objective: To investigate alterations in melanin and melanocytes in melasma before and after laser treatment using optical coherence tomography (OCT).

Methods: Eight female melasma patients were enrolled in Taiwan. Based on the baseline OCT scans, the patients were categorized into either epidermal-type or mixed-type melasma and were assigned different treatment protocols accordingly. Sequential OCT images were collected from melasma lesions and normal skin at baseline, Week 4 and Week 8.

Results: After 8 weeks of laser treatment, the mean Melasma Area Severity Index (MASI) score improved from 10.92 to 6.30. Results from OCT showed no significant changes in the normalized density, area, or intensity of melanin in both lesional and normal skin. At baseline, the mean length of dendritic melanocytes in the affected skin was 15% longer than those in normal skin; at Week 8, the mean length of lesional dendritic melanocytes became the same as those in normal skin. Additionally, the mean width of dendritic melanocytes decreased from being 4% wider to only 2% wider than those in normal skin.

Conclusion: After 8 weeks of treatment, an improvement of MASI score was noted, mainly attributable to a reduction in lesional area. OCT showed no notable change regarding melanin, but a decrease in length and width of dendritic melanocytes was noted in the lesional skin of melasma patients.

References

Ren R, Bao S, Qian W, Zhao H . Efficacy and Safety of Picosecond Laser in the Treatment of Melasma: A Network Meta-analysis. Dermatol Surg. 2023; 49(5S):S49-S55. DOI: 10.1097/DSS.0000000000003775. View

Kang H, Bahadoran P, Suzuki I, Zugaj D, Khemis A, Passeron T . In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution. Exp Dermatol. 2010; 19(8):e228-33. DOI: 10.1111/j.1600-0625.2009.01057.x. View

Griffiths C, Finkel L, Hamilton T, Ellis C, Voorhees J . Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol. 1994; 130(6):727-33. View

Handel A, Lima P, Tonolli V, Miot L, Miot H . Risk factors for facial melasma in women: a case-control study. Br J Dermatol. 2014; 171(3):588-94. DOI: 10.1111/bjd.13059. View

Chalermchai T, Rummaneethorn P . Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma. J Cosmet Laser Ther. 2017; 20(3):134-139. DOI: 10.1080/14764172.2017.1376098. View

Pandya A, Hynan L, Bhore R, Riley F, Guevara I, Grimes P . Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol. 2010; 64(1):78-83, 83.e1-2. DOI: 10.1016/j.jaad.2009.10.051. View

Wu D, Goldman M, Wat H, Chan H . A Systematic Review of Picosecond Laser in Dermatology: Evidence and Recommendations. Lasers Surg Med. 2020; 53(1):9-49. DOI: 10.1002/lsm.23244. View

Wang Y, Wang J, Wu Y . Application of Cellular Resolution Full-Field Optical Coherence Tomography in vivo for the Diagnosis of Skin Tumours and Inflammatory Skin Diseases: A Pilot Study. Dermatology. 2021; 238(1):121-131. DOI: 10.1159/000514686. View

Chen I, Wang Y, Chang C, Wu Y, Lu C, Shen J . Computer-Aided Detection (CADe) System with Optical Coherent Tomography for Melanin Morphology Quantification in Melasma Patients. Diagnostics (Basel). 2021; 11(8). PMC: 8391880. DOI: 10.3390/diagnostics11081498. View

10.

Ortonne J, Arellano I, Berneburg M, Cestari T, Chan H, Grimes P . A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol. 2009; 23(11):1254-62. DOI: 10.1111/j.1468-3083.2009.03295.x. View

11.

Grimes P, Yamada N, Bhawan J . Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma. Am J Dermatopathol. 2005; 27(2):96-101. DOI: 10.1097/01.dad.0000154419.18653.2e. View

12.

Gao Y, Jia X, Wang M, Hua Y, Zheng H, Xiang W . Melanocyte activation and skin barrier disruption induced in melasma patients after 1064 nm Nd:YAG laser treatment. Lasers Med Sci. 2018; 34(4):767-771. DOI: 10.1007/s10103-018-2658-7. View

13.

Handel A, Miot L, Miot H . Melasma: a clinical and epidemiological review. An Bras Dermatol. 2014; 89(5):771-82. PMC: 4155956. DOI: 10.1590/abd1806-4841.20143063. View

14.

O Connor K, Cho S, Chung H . Wound Healing Profile After 1064- and 532-nm Picosecond Lasers With Microlens Array of In Vivo Human Skin. Lasers Surg Med. 2021; 53(8):1059-1064. DOI: 10.1002/lsm.23390. View

15.

Hwang C, Chen C . Serial change in laser-induced optical breakdown by 1064-nm Nd:YAG picosecond laser. Photodermatol Photoimmunol Photomed. 2019; 36(1):63-64. DOI: 10.1111/phpp.12505. View

16.

Wang Y, Chang C, Wu Y, Huang L, Shen J, Lu M . Adaptability of melanocytes post ultraviolet stimulation in patients with melasma. Lasers Surg Med. 2023; 55(7):680-689. DOI: 10.1002/lsm.23699. View